Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

December 2012 - FRMC

Cardiogenic Shock Complicating Acute Myocardial Infarction
12/17/2012
Results of a randomized, prospective, open-label, multicenter trial [N Engl J Med. 2012; DOI:10.1056/NEJMoa1208410] showed no significant reduction in 30-day mortality in patients with cardiogenic shock complicating acute myocardial...
Results of a randomized, prospective, open-label, multicenter trial [N Engl J Med. 2012; DOI:10.1056/NEJMoa1208410] showed no significant reduction in 30-day mortality in patients with cardiogenic shock complicating acute myocardial...
Results of a randomized,...
12/17/2012
First Report Managed Care
Older Patients with Mantle-Cell Lymphoma
12/17/2012
The long-term prognosis for older patients with mantle-cell lymphoma is poor. Only a minority of patients have a complete remission, and relapse or progression usually occurs within 2 to 3 years, resulting in an overall survival of <5...
The long-term prognosis for older patients with mantle-cell lymphoma is poor. Only a minority of patients have a complete remission, and relapse or progression usually occurs within 2 to 3 years, resulting in an overall survival of <5...
The long-term prognosis for...
12/17/2012
First Report Managed Care
JAK Inhibitor Shows Improvement in Moderate-to-Severe Ulcerative Colitis
12/17/2012
Patients with active ulcerative colitis and treated with the selective oral Janus kinase inhibitor tofacitinib were more likely to show clinical response and remission.
Patients with active ulcerative colitis and treated with the selective oral Janus kinase inhibitor tofacitinib were more likely to show clinical response and remission.
Patients with active ulcerative...
12/17/2012
First Report Managed Care
Lipid-Modifying Therapies Lower Risk of Pancreatitis
12/17/2012
The intensity of pancreatitis can range from a mild, self-limiting episode to a severe or even fatal event. There have been case reports and studies suggesting that pancreatitis may be caused by statin use. According to researchers, few of...
The intensity of pancreatitis can range from a mild, self-limiting episode to a severe or even fatal event. There have been case reports and studies suggesting that pancreatitis may be caused by statin use. According to researchers, few of...
The intensity of pancreatitis...
12/17/2012
First Report Managed Care
Healthcare Reform and Patients with HIV
12/17/2012
Ensuring that all individuals in the United States who are living with HIV have access to quality healthcare has been a challenge since the onset of the epidemic. The Patient Protection and Affordable Care Act (ACA) is designed to expand...
Ensuring that all individuals in the United States who are living with HIV have access to quality healthcare has been a challenge since the onset of the epidemic. The Patient Protection and Affordable Care Act (ACA) is designed to expand...
Ensuring that all individuals in...
12/17/2012
First Report Managed Care

News

News
An Algorithm to Detect Multiple Sclerosis Relapses
12/17/2012
Multiple sclerosis (MS) is a multi-faceted autoimmune demyelinating disorder affecting >400,000 individuals in the United States. Prevention of relapses in patients with MS is a primary goal of MS therapy. Confirmation of a relapse in...
Multiple sclerosis (MS) is a multi-faceted autoimmune demyelinating disorder affecting >400,000 individuals in the United States. Prevention of relapses in patients with MS is a primary goal of MS therapy. Confirmation of a relapse in...
Multiple sclerosis (MS) is a...
12/17/2012
First Report Managed Care
News
Interferon Beta and Disability in Patients with RRMS
12/17/2012
Multiple sclerosis (MS), a chronic condition that usually affects people in the prime of their lives, is characterized by clinical progression over time manifested by the accumulation of disability. The most widely prescribed...
Multiple sclerosis (MS), a chronic condition that usually affects people in the prime of their lives, is characterized by clinical progression over time manifested by the accumulation of disability. The most widely prescribed...
Multiple sclerosis (MS), a...
12/17/2012
First Report Managed Care
News
Cost-Effectiveness of MS Therapy
12/17/2012
The most common disabling neurologic disease among adults 18 to 60 years of age is multiple sclerosis (MS). Disease-modifying therapies (DMTs) are the gold standard of disease management for MS, with the goal of preventing or delaying...
The most common disabling neurologic disease among adults 18 to 60 years of age is multiple sclerosis (MS). Disease-modifying therapies (DMTs) are the gold standard of disease management for MS, with the goal of preventing or delaying...
The most common disabling...
12/17/2012
First Report Managed Care
News
Oral BG-12 or Glatiramer Acetate for Multiple Sclerosis
12/17/2012
Parenteral agents (interferon beta and glatiramer acetate) are common treatments for multiple sclerosis (MS), a chronic demyelinating and neurodegenerative disease of the central nervous system. According to researchers, oxidative stress and...
Parenteral agents (interferon beta and glatiramer acetate) are common treatments for multiple sclerosis (MS), a chronic demyelinating and neurodegenerative disease of the central nervous system. According to researchers, oxidative stress and...
Parenteral agents (interferon...
12/17/2012
First Report Managed Care

Department

Conference Insider
Keys to Success in Healthcare
12/17/2012
Las Vegas—It is no secret healthcare providers are facing challenges. Hospitals and physicians have struggled with reimbursement and profitability. They are also concerned with selected provisions of the Patient Protection and Affordable Care...
Las Vegas—It is no secret healthcare providers are facing challenges. Hospitals and physicians have struggled with reimbursement and profitability. They are also concerned with selected provisions of the Patient Protection and Affordable Care...
Las Vegas—It is no secret...
12/17/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Gilead Unveils Promising Hep C, Fatty Liver Data; Setbacks Elsewhere
10/20/2016
Gilead Sciences recently announced trial data showing high cure rates across all types of hepatitis C in late stage studies for a triple drug combination therapy.
Gilead Sciences recently announced trial data showing high cure rates across all types of hepatitis C in late stage studies for a triple drug combination therapy.
Gilead Sciences recently...
10/20/2016
First Report Managed Care
Conference Coverage
Treatment Costs, Care of Patients With Metastatic Breast Cancer in the United States
06/10/2022
Costs related to metastatic breast cancer vary by receptor subtype as well as the number of years postdiagnosis, according to research presented at the 2022 ASCO Annual Meeting.
Costs related to metastatic breast cancer vary by receptor subtype as well as the number of years postdiagnosis, according to research presented at the 2022 ASCO Annual Meeting.
Costs related to metastatic...
06/10/2022
First Report Managed Care
Novel Monoclonal Antibody to PCSK9
07/23/2012
Studies of animal models have found that proprotein convertase subtilisin/kexin 9 (PCSK9), one of the serine proteases, has a role in the post-translational regulation of LDL-receptor activity. PCSK9, which is synthesized primarily in the...
Studies of animal models have found that proprotein convertase subtilisin/kexin 9 (PCSK9), one of the serine proteases, has a role in the post-translational regulation of LDL-receptor activity. PCSK9, which is synthesized primarily in the...
Studies of animal models have...
07/23/2012
First Report Managed Care
News
Court questions limits on use of prescription data
04/27/2011
04/27/2011
First Report Managed Care
News
Research Finds Link Between Poor Health And Seniors Switching Out Of Private Medicare Plans
02/05/2013
02/05/2013
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

December 2012 Volume 9 Issue 12

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement